Red List:Official warnings and scam reports, with sourcesCheck a link
Check a link
Regulatory warningOfficial actionRegulatory note

Dispensed Pty Ltd

Paid six TGA infringement notices totalling A$118,800 over alleged advertising of medicinal cannabis

This entry is about Australia — not the country you picked in the header.

According to Therapeutic Goods Administration (Australia), Sep 22, 2025 · Read the source

Where
Australia
First reported
Last checked

Summary

Dispensed Pty Ltd, an Australian company, was issued six infringement notices totalling A$118,800 and a direction notice by the Therapeutic Goods Administration (TGA), which announced the action on September 22, 2025. The TGA alleges that the company advertised prescription-only medicinal cannabis to the public on third-party websites and social media, including through indirect terms such as 'plant medicine' and 'cannabinoid-based therapies'. Australian law does not allow prescription medicines, including medicinal cannabis, to be advertised to consumers. The TGA said Dispensed paid the notices in September 2025. The direction notice requires the company to stop all medicinal cannabis advertising, including on platforms run by third parties, to retrieve printed material such as flyers and posters still in circulation, and to report evidence of its compliance to the regulator.

What the source found

  • The TGA alleges advertising of prescription-only medicinal cannabis on third-party websites and social media.
  • Indirect references such as 'plant medicine' and 'cannabinoid-based therapies' were cited.
  • Six infringement notices totalling A$118,800 were issued and paid in September 2025.
  • A direction notice requires the company to cease advertising, recall printed materials and report compliance.

Products named

  • medicinal cannabis (prescription-only)

Timeline

  1. TGA announces infringement notices (paid September 2025) and direction notice

Sources

  1. Regulator

Wording on this page follows the sources. Found an error? See the corrections process in our editorial policy.

Status notes

Advertising matter under Australia's Therapeutic Goods Act; not an allegation about product quality. Notices were paid; the TGA describes the contraventions as alleged.

Comments

No comments yet.

Comments are read by a moderator before they’re published.

The full Red List
Regulatory warningOfficial action

Vitanabis Intermediação e Serviços Ltda.

Vitanabis

Anvisa prohibited all cannabis derivatives sold by Vitanabis and advertised online

Brazil · Aug 3, 2026
Regulatory warningOfficial action

Leve CDB

Leve CDB

Anvisa prohibited the Leve CDB Full Spectrum cannabis oil 6,000 mg sold through its official website

Brazil · Dec 9, 2025
Regulatory warningOfficial action

Cannabis Oil

cpag.supersalelinks[.]org/ujih/

Listed by Czech medicines regulator SÚKL as a website illegally offering an unapproved 'Cannabis Oil' preparation

Czechia · Oct 31, 2025
Report a seller

Tell us what happened

Every report is read by a person. You don’t need to prove anything, and we never publish your name.

What happens next
  • A moderator reads your report and checks the link against the Red List and our seller records.
  • We look for an authoritative source — a regulator, court, police or consumer-protection finding.
  • When a source confirms it, your report is linked to a Red List entry. Your name and contact details stay private.
Report a seller

Self-check · 2 minutes · private

Is cannabis becoming a problem for you?

Eight questions from CUDIT-R, a screening test used by clinicians. Your answers never leave this page.